Dishman Carbogen Amcis Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹851.40 crore, reflecting a quarter-on-quarter *(QoQ) increase of 18.28 per cent from ₹719.80 crore. This corresponds to a year-on-year *(YoY) growth of 18.85 per cent.
Operating Profit
Operating Profit stands at ₹161.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 43.05 per cent from ₹113.11 crore. This corresponds to a year-on-year *(YoY) growth of 14.80 per cent.
PBDT
PBDT stands at ₹134.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 82.37 per cent from ₹73.98 crore. This corresponds to a year-on-year *(YoY) growth of 26.34 per cent.
Profit Before Tax
Profit Before Tax stands at ₹46.13 crore, reflecting a quarter-on-quarter *(QoQ) increase of 541.86 per cent from ₹-10.44 crore. This corresponds to a year-on-year *(YoY) growth of 66.53 per cent.
Net Profit
Net Profit stands at ₹21.74 crore, reflecting a quarter-on-quarter *(QoQ) increase of 267.62 per cent from ₹-12.97 crore. This represents a 49.55 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Dishman Carbogen Amcis Ltd Earnings
- YOY
- QOQ
Dishman Carbogen Amcis Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Dishman Carbogen Amcis Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Dishman Carbogen Amcis Ltd Financial Reports
Dishman Carbogen Amcis Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dishman Carbogen | -0.25% | 11.90% | 6.52% | 30.47% | -25.47% | -26.25% |
| Morepen Labs. | 3.03% | 2.76% | 41.98% | 58.99% | 46.63% | -4.58% |
| Panacea Biotec | -2.35% | -5.28% | -2.99% | 66.52% | 39.87% | 32.08% |
| Unichem Labs. | -1.96% | -0.09% | 29.92% | 47.75% | 6.56% | -22.80% |
| Kwality Pharma | -0.85% | -5.31% | 16.83% | 77.03% | 135.55% | 127.28% |
| Hikal | -0.54% | -0.11% | 23.02% | 33.90% | -1.01% | -35.32% |
| Sai Parenteral's | -1.25% | 4.13% | 11.15% | 49.38% | 50.62% | 50.62% |
Company Info
Company Information
WTD & Executive Director : Deohooti J Vyas
ED / Global MD / Promoter : Arpit J Vyas
Independent Non Exe. Director : KULIN NALINKANT SHAH
Independent Non Exe. Director : Hemantkumar J Bhatt
Independent Non Exe. Director : Margie S Parikh
Non-Exec & Non-Independent Dir : Dhaval R. Shah
Company Sec. & Compli. Officer : Shrima Dave